Study the Efficacy of Epidiolex for Typical Absence Seizures

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Study the Efficacy of Epidiolex for Typical Absence Seizures trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 4

NCT04899050

Epidiolex in Typical Absence Seizures

This is a Pilot study, open-label study consisting of a screening period of up to 4 weeks, a 4-week dose-titration treatment period to dose of up to 20 mg/kg/da…

United States14 participantsStarted 2021-07-30

Treatment: Cannabidiol (Epidiolex)